It has been shown that ATM loss is synthetic lethal with DNA-PK (30, 31) and more than 20% of non–small cell lung cancer (NSCLC) cell lines are ATM deficient (32, 33). This evidence concerns the gene ATM and non-small cell lung carcinoma.